Drug search by name

Ruxolitinib and Lipid elevations

Result of checking the interaction of drug Ruxolitinib and disease Lipid elevations for safety when used together.

Check result:

Ruxolitinib <> Lipid elevations

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of ruxolitinib may increase total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides. It is recommended to assess lipid parameters approximately 8-12 weeks following initiation of therapy and to monitor and treat per clinical guidelines for the management of hyperlipidemia. Care should be exercised when using this agent in patients with lipids disorders.

Ruxolitinib

Generic Name: ruxolitinib

Brand Name: Jakafi

Synonyms: n.a.

What is Ruxolitinib?